$BRKR (BRUKER) — 8-K: Bruker Q1 2026 revenue $823.4M; recast segments show BSI CALID at $316.3M

Total revenue from external customers was $823.4M for the three months ended March 31, 2026, with total segment revenue of $826.6M including $3.2M intersegment revenue. Gross profit was $379.8M at a 46.1% margin, and operating income was $10.2M at a 1.2% operating margin. Under the recast presentation, BSI CALID contributed $316.3M in external revenue, BSI NANO $246.0M, BSI Biosystems $197.5M, and BEST $63.6M. BSI NANO posted an operating loss of $21.8M, while Corporate recorded a $32.2M operating loss.

Total revenue from external customers was $823.4M for the three months ended March 31, 2026, with total segment revenue of $826.6M including $3.2M intersegment revenue. Gross profit was $379.8M at a 4